FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138198874> ?p ?o ?g. }

• W2138198874 endingPage "3227" @default.
• W2138198874 startingPage "3221" @default.
• W2138198874 abstract "Abstract A retrospective analysis of granulocyte colony-stimulating factor (G-CSF)–mobilized peripheral blood mononuclear cell (G-PBMC) products harvested from healthy donors indicates significant variability in both the absolute number and relative proportion of CD34, CD3, and CD14 cells obtained. This report examined whether variations in the cellular composition of G-PBMC products correlated with clinical outcomes after myeloablative allogeneic transplantation. The numbers of CD34, CD3, and CD14 cells infused into 181 human leukocyte antigen (HLA)–identical sibling recipients were analyzed with respect to tempo of engraftment, acute graft-versus-host-disease (GVHD), clinical extensive chronic GVHD, overall survival, and disease relapse. Neither acute GVHD, overall survival, nor disease relapse was statistically significantly associated with CD34, CD3, or CD14 cell doses or the CD14 to CD3 ratio. CD3 and CD14 cell doses and CD14 to CD3 ratios did not correlate with the tempo of neutrophil and platelet engraftment. However, increasing CD34 cell numbers were significantly associated with accelerated neutrophil (P = .03) and platelet (P = .01) engraftment. Higher doses of CD34 cells (&gt; 8.0 × 106/kg) were also associated with a significantly increased hazard of clinical extensive chronic GVHD (HR = 2.3, 95% confidence interval [CI] 1.4-3.7,P = .001), but neither CD3 nor CD14 doses were statistically significantly associated with chronic GVHD. It was concluded that CD34 cell dose in G-PBMC grafts appears to affect both the engraftment kinetics and the development of clinical extensive chronic GVHD in HLA-identical sibling recipients but without a demonstrable impact on survival, relapse, and acute GVHD. Given the morbidity associated with extensive chronic GVHD, efforts to further accelerate engraftment in HLA-matched sibling transplants by increasing CD34 cell number in G-PBMC products may be counterproductive." @default.
• W2138198874 created "2016-06-24" @default.
• W2138198874 creator A5006705594 @default.
• W2138198874 creator A5008632674 @default.
• W2138198874 creator A5013130893 @default.
• W2138198874 creator A5016644532 @default.
• W2138198874 creator A5045089433 @default.
• W2138198874 creator A5059063645 @default.
• W2138198874 creator A5060494598 @default.
• W2138198874 creator A5070819714 @default.
• W2138198874 creator A5071375525 @default.
• W2138198874 creator A5079728501 @default.
• W2138198874 creator A5084879148 @default.
• W2138198874 creator A5085787488 @default.
• W2138198874 date "2001-12-01" @default.
• W2138198874 modified "2023-10-13" @default.
• W2138198874 title "CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantation" @default.
• W2138198874 cites W1274344746 @default.
• W2138198874 cites W1539005347 @default.
• W2138198874 cites W1620751085 @default.
• W2138198874 cites W1934677454 @default.
• W2138198874 cites W1965974612 @default.
• W2138198874 cites W1973617793 @default.
• W2138198874 cites W2007730297 @default.
• W2138198874 cites W2026773500 @default.
• W2138198874 cites W2038148110 @default.
• W2138198874 cites W2067480394 @default.
• W2138198874 cites W2071360821 @default.
• W2138198874 cites W2086882995 @default.
• W2138198874 cites W2155386340 @default.
• W2138198874 cites W2168725395 @default.
• W2138198874 cites W2172131336 @default.
• W2138198874 cites W2190162667 @default.
• W2138198874 cites W2217873455 @default.
• W2138198874 cites W2247696063 @default.
• W2138198874 cites W2248611751 @default.
• W2138198874 cites W2262982217 @default.
• W2138198874 cites W2316205577 @default.
• W2138198874 cites W2333915107 @default.
• W2138198874 cites W2337680764 @default.
• W2138198874 cites W2400090911 @default.
• W2138198874 cites W289749226 @default.
• W2138198874 cites W312886274 @default.
• W2138198874 cites W4293241248 @default.
• W2138198874 doi "https://doi.org/10.1182/blood.v98.12.3221" @default.
• W2138198874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11719357" @default.
• W2138198874 hasPublicationYear "2001" @default.
• W2138198874 type Work @default.
• W2138198874 sameAs 2138198874 @default.
• W2138198874 citedByCount "222" @default.
• W2138198874 countsByYear W21381988742012 @default.
• W2138198874 countsByYear W21381988742013 @default.
• W2138198874 countsByYear W21381988742014 @default.
• W2138198874 countsByYear W21381988742015 @default.
• W2138198874 countsByYear W21381988742016 @default.
• W2138198874 countsByYear W21381988742017 @default.
• W2138198874 countsByYear W21381988742018 @default.
• W2138198874 countsByYear W21381988742019 @default.
• W2138198874 countsByYear W21381988742020 @default.
• W2138198874 countsByYear W21381988742021 @default.
• W2138198874 countsByYear W21381988742022 @default.
• W2138198874 countsByYear W21381988742023 @default.
• W2138198874 crossrefType "journal-article" @default.
• W2138198874 hasAuthorship W2138198874A5006705594 @default.
• W2138198874 hasAuthorship W2138198874A5008632674 @default.
• W2138198874 hasAuthorship W2138198874A5013130893 @default.
• W2138198874 hasAuthorship W2138198874A5016644532 @default.
• W2138198874 hasAuthorship W2138198874A5045089433 @default.
• W2138198874 hasAuthorship W2138198874A5059063645 @default.
• W2138198874 hasAuthorship W2138198874A5060494598 @default.
• W2138198874 hasAuthorship W2138198874A5070819714 @default.
• W2138198874 hasAuthorship W2138198874A5071375525 @default.
• W2138198874 hasAuthorship W2138198874A5079728501 @default.
• W2138198874 hasAuthorship W2138198874A5084879148 @default.
• W2138198874 hasAuthorship W2138198874A5085787488 @default.
• W2138198874 hasBestOaLocation W21381988741 @default.
• W2138198874 hasConcept C10205521 @default.
• W2138198874 hasConcept C114684123 @default.
• W2138198874 hasConcept C126322002 @default.
• W2138198874 hasConcept C137061746 @default.
• W2138198874 hasConcept C147483822 @default.
• W2138198874 hasConcept C167672396 @default.
• W2138198874 hasConcept C202751555 @default.
• W2138198874 hasConcept C203014093 @default.
• W2138198874 hasConcept C2776694085 @default.
• W2138198874 hasConcept C2777767877 @default.
• W2138198874 hasConcept C2777983669 @default.
• W2138198874 hasConcept C2778513237 @default.
• W2138198874 hasConcept C2779972918 @default.
• W2138198874 hasConcept C28328180 @default.
• W2138198874 hasConcept C2911091166 @default.
• W2138198874 hasConcept C54355233 @default.
• W2138198874 hasConcept C55493867 @default.
• W2138198874 hasConcept C71924100 @default.
• W2138198874 hasConcept C86803240 @default.
• W2138198874 hasConcept C8891405 @default.
• W2138198874 hasConceptScore W2138198874C10205521 @default.
• W2138198874 hasConceptScore W2138198874C114684123 @default.

• next